Cardiac Patients and Noncardiac Surgery: Pathophysiological Basis for Clinical Management

  • G. Frasacco
  • L. TritapepeEmail author


Improvement in heart failure therapy and perioperative management (technology and hemodynamic monitoring system) has led to an increasing number of cardiac patients eligible for anesthesia and surgery.

Patients who underwent previous surgical correction of VHD (valvular heart disease) and have a prosthetic (biological or mechanical) valve can undergo noncardiac surgery without additional risk, provided that there is no evidence of valve or ventricular dysfunction (tested with echocardiographic evaluation). They clearly need a modification of anticoagulant regimen in the perioperative period. Antibiotic prophylaxis is recommended in all patients at intermediate or high risk of infective endocarditis in the field of noncardiac surgery.

Patients with coronary stents need an accurate evaluation and management of antiplatelet therapy to avoid stent thrombosis.

In this chapter we will discuss the physiopathology of the most frequent heart diseases, excluding the rarer or congenital ones.


Ischemic heart disease Valve heart disease Transesophageal echocardiography Cardiac anesthesia Anesthesia in noncardiac surgery 


  1. 1.
    Akhtar S, Silverman D. Assessment and management of patients with ischemic heart disease. Crit Care Med. 2004;32(4 Suppl):S126–36.CrossRefGoogle Scholar
  2. 2.
    Chassot P-G, Delabays A, Spahn DR. Preoperative evaluation of patients with, or at risk of, coronary artery disease undergoing non-cardiac surgery. Br J Anaesth. 2002;89:747–59.CrossRefGoogle Scholar
  3. 3.
    Karthikeyan G, Bhargava B. Managing patients undergoing non-cardiac surgery. Heart. 2006;92:17–20.CrossRefGoogle Scholar
  4. 4.
    Kristensen SD, et al. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J. 2014;35(35):2383–431.CrossRefGoogle Scholar
  5. 5.
    Lee TH, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999;100:1043–9.CrossRefGoogle Scholar
  6. 6.
    Konstadt S. Anesthesia for non-cardiac surgery in the patient with cardiac disease. Can J Anesth. 2005;52(Suppl. 1):R7.Google Scholar
  7. 7.
    Stoelting RK, Dierdorf SF. Anesthesia and co-existing disease. 4th ed. New York, NY: Churchill Livingstone; 2002. p. 105–16.Google Scholar
  8. 8.
    ACC/AHA. Guidelines for the management of patients with valvular heart disease. JACC. 2006;48:1–148.CrossRefGoogle Scholar
  9. 9.
    Supino PG, Borer JS, Preibisz J, Bornstein A. The epidemiology of valvular heart disease: growing public health problem. Heart Fail Clin. 2006;2:379–93.CrossRefGoogle Scholar
  10. 10.
    Kertai MD, et al. Aortic stenosis: an underestimated risk factor for perioperative complications in patients undergoing noncardiac surgery. Am J Med. 2004;116:8–13.CrossRefGoogle Scholar
  11. 11.
    Mochizuki Y, Pandian NG. Role of echocardiography in the diagnosis and treatment of patients with aortic stenosis. Curr Opin Cardiol. 2003;18:327–33.CrossRefGoogle Scholar
  12. 12.
    Mittnacht AJ, Fanshawe M, Konstadt S. Anesthetic considerations in the patient with valvular heart disease for non cardiac surgery. Semin Cardiothorac Vasc Anesth. 2008;12(1):33–59.CrossRefGoogle Scholar
  13. 13.
    Christ M, Sharkova Y, Gelener G, Maisch B. Preoperative and perioperative care for patients with suspected or established aortic stenosis facing noncardiac surgery. Chest. 2005;128:2944–53.CrossRefGoogle Scholar
  14. 14.
    Bekeredjian R, Grayburn PA. Valvular heart disease: aortic regurgitation. Circulation. 2005;112:125–34.CrossRefGoogle Scholar
  15. 15.
    Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, Nihoyannopoulos P, Otto CM, Quinones MA, Rakowski H, Stewart WJ, Waggoner A, Weissman NJ, American Society of Echocardiography. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr. 2003;16:777–802.CrossRefGoogle Scholar
  16. 16.
    Messika-Zeitoun D, Lung B, Brochet E, Himbert D, Serfaty JM, Laissy JP, Vahanian A. Evaluation of mitral stenosis in 2008. Arch Cardiovasc Dis. 2008;101:653–63.CrossRefGoogle Scholar
  17. 17.
    Klein AJ, Carroll JD. Left ventricular dysfunction and mitral stenosis. Heart Fail Clin. 2006;2:443–52.CrossRefGoogle Scholar
  18. 18.
    Carabello BA. The current therapy for mitral regurgitation. J Am Coll Cardiol. 2008;52:319–26.CrossRefGoogle Scholar
  19. 19.
    Ramakrishna G, Sprung J, Ravi BS, et al. Impact of pulmonary hypertension on the outcomes of noncardiac surgery predictors of perioperative morbidity and mortality. J Am Coll Cardiol. 2005;45:1691–9.CrossRefGoogle Scholar
  20. 20.
    Behnia R, Molteni A, Igic R. Angiotensin-converting enzyme inhibitors: mechanisms of action and implications in anesthesia practice. Curr Pharm Des. 2003;9:763–76.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Policlinico Casilino HospitalRomeItaly
  2. 2.Sapienza University of Rome, Policlinico Umberto I HospitalRomeItaly

Personalised recommendations